MCID: CRY003
MIFTS: 51

Cryptosporidiosis

Categories: Rare diseases, Infectious diseases, Gastrointestinal diseases

Aliases & Classifications for Cryptosporidiosis

MalaCards integrated aliases for Cryptosporidiosis:

Name: Cryptosporidiosis 12 72 49 55 51 40 3 41 14 69
Cryptosporidial Gastroenteritis 12 69
Infection by Cryptosporidium 12
Intestinal Cryptosporidiosis 12

Characteristics:

Orphanet epidemiological data:

55
cryptosporidiosis
Inheritance: Not applicable; Prevalence: 1-9/100000 (United States),1-9/100000 (Europe); Age of onset: All ages; Age of death: normal life expectancy;

Classifications:

Orphanet: 55  
Rare infectious diseases


External Ids:

Disease Ontology 12 DOID:1733
ICD10 32 A07.2
ICD9CM 34 007.4
MeSH 41 D003457
Orphanet 55 ORPHA1549
MESH via Orphanet 42 D003457
UMLS via Orphanet 70 C0010418
ICD10 via Orphanet 33 A07.2

Summaries for Cryptosporidiosis

MedlinePlus : 40 Cryptosporidiosis (crypto) is an illness caused by a parasite. The parasite lives in soil, food, and water. It may also be on surfaces that have been contaminated with feces (poop). You can become infected by swallowing the parasite, if it is in your food, drinking water, or water that you swim in. You can also get it by touching your mouth with contaminated hands. The most common symptom of crypto is watery diarrhea. Other symptoms include Dehydration Weight loss Stomach cramps or pain Fever Nausea Vomiting Contact your health care provider if you have watery diarrhea that lasts more than a few days. Most people with crypto get better without treatment within one to two weeks. But crypto can cause serious problems in people with weak immune systems, like those with HIV/AIDS. To reduce your risk of crypto, wash your hands often, only drink water that you know is safe, and wash or peel fresh fruits and vegetables before eating. Centers for Disease Control and Prevention

MalaCards based summary : Cryptosporidiosis, also known as cryptosporidial gastroenteritis, is related to giardiasis and diarrhea, and has symptoms including pruritus and fever. An important gene associated with Cryptosporidiosis is CD79A (CD79a Molecule), and among its related pathways/superpathways are Sudden Infant Death Syndrome (SIDS) Susceptibility Pathways and Primary immunodeficiency. The drugs Nitazoxanide and Azithromycin have been mentioned in the context of this disorder. Affiliated tissues include small intestine, lung and breast, and related phenotype is immune system.

NIH Rare Diseases : 49 Cryptosporidiosis is an illness caused by the parasite, Cryptosporidium. The condition is most commonly associated with watery diarrhea. Other signs and symptoms may include dehydration, weight loss, stomach cramps, fever, nausea and/or vomiting. Cryptosporidiosis occurs when the parasite enters the body, often through contaminated food and water or because of poor handwashing hygiene. Although cryptosporidiosis can affect all people, young children, pregnant women and people with severely weakened immune systems (i.e. those with AIDS; cancer and transplant patients who are taking certain immunosuppressive drugs; and those with inherited diseases that affect the immune system) are likely to develop a more serious illness. Medications such as nitazoxanide have been used to treat diarrhea in both adults and children. However, most people who have healthy immune systems will recover without treatment. Last updated: 3/22/2017

CDC : 3 Cryptosporidium is a microscopic parasite that causes the diarrheal disease cryptosporidiosis. Both the parasite and the disease are commonly known as "Crypto."

Disease Ontology : 12 A coccidiosis that involves a parasitic protozoan infection of the intestine of humans and a wide range of animals caused by Cryptosporidium species, through contaminated water and food, The symptoms include watery diarrhea, dehydration, weight loss, abdominal pain, fever, nausea and vomiting. Cryptosporidium infections have also been found in other digestive tract organs, the lungs, and conjunctiva. Immunocompromised persons are at greater risk of developing the infection.

Wikipedia : 72 Cryptosporidiosis, also known as crypto, is a parasitic disease caused by Cryptosporidium, a genus of... more...

Related Diseases for Cryptosporidiosis

Diseases related to Cryptosporidiosis via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 223)
# Related Disease Score Top Affiliating Genes
1 giardiasis 31.1 CD40LG CD79A
2 diarrhea 30.8 CD40LG CD79A SST
3 cd40 ligand deficiency 30.2 CD40LG CD79A
4 coccidiosis 30.1 BFSP2 CD40LG CD79A
5 amebiasis 30.1 CD40LG CD79A
6 secretory diarrhea 30.1 SST VIP
7 chickenpox 30.1 CD40LG CD79A
8 strongyloidiasis 29.8 CCL11 CD79A
9 toxoplasmosis 29.8 CD40LG CD79A DHFR
10 pneumocystosis 29.3 CD40LG CD79A DHFR
11 parasitic protozoa infectious disease 29.3 CD40LG CD79A DHFR
12 gastrointestinal system disease 29.2 CCL11 CD40LG CD79A SST
13 malaria 28.1 CCL11 CD40LG CXCL10 DHFR IL1A
14 cryptorchidism, unilateral or bilateral 10.9
15 il21r immunodeficiency 10.9
16 encapsulated thymoma 10.6 CD79A SST
17 selective igg deficiency disease 10.5 CD40LG CD79A
18 c1q nephropathy 10.5 CD40LG CD79A
19 meningovascular neurosyphilis 10.5 CD40LG CD79A
20 alpha chain disease 10.5 CD40LG CD79A
21 brill-zinsser disease 10.5 CD40LG CD79A
22 exudative glomerulonephritis 10.5 CD40LG CD79A
23 cork-handlers' disease 10.5 CD40LG CD79A
24 salpingo-oophoritis 10.5 CD40LG CD79A
25 early yaws 10.5 CD40LG CD79A
26 ventilation pneumonitis 10.5 CD40LG CD79A
27 chronic interstitial cystitis 10.5 CD40LG CD79A
28 axillary adenitis 10.5 CD40LG CD79A
29 cryofibrinogenemia 10.5 CD40LG CD79A
30 trichostrongyloidiasis 10.5 CD40LG CD79A
31 subacute bacterial endocarditis 10.5 CD40LG CD79A
32 heterophyiasis 10.5 CD40LG CD79A
33 immunoglobulin g deficiency 10.5 CD40LG CD79A
34 orbital granuloma 10.5 CD40LG CD79A
35 transient hypogammaglobulinemia of infancy 10.5 CD40LG CD79A
36 hyperglobulinemic purpura 10.5 CD40LG CD79A
37 gastroduodenitis 10.5 CD40LG CD79A
38 bacterial conjunctivitis 10.5 CD40LG CD79A
39 heavy chain disease 10.5 CD40LG CD79A
40 ophthalmia neonatorum 10.5 CD40LG CD79A
41 immunoglobulin a deficiency 1 10.5 CD40LG CD79A
42 parotid disease 10.5 CD40LG CD79A
43 cerebral arteritis 10.5 CD40LG CD79A
44 selective immunoglobulin deficiency disease 10.5 CD40LG CD79A
45 geniculate herpes zoster 10.5 CD40LG CD79A
46 erythema elevatum diutinum 10.5 CD40LG CD79A
47 neuroschistosomiasis 10.5 CD79A TAC1
48 sporotrichosis 10.5 CD40LG CD79A
49 fallopian tube disease 10.5 CD40LG CD79A
50 hyperimmunoglobulin syndrome 10.5 CD40LG CD79A

Graphical network of the top 20 diseases related to Cryptosporidiosis:



Diseases related to Cryptosporidiosis

Symptoms & Phenotypes for Cryptosporidiosis

UMLS symptoms related to Cryptosporidiosis:


pruritus, fever

MGI Mouse Phenotypes related to Cryptosporidiosis:

43
# Description MGI Source Accession Score Top Affiliating Genes
1 immune system MP:0005387 9.23 CCL11 CD40LG CD79A CXCL10 DHFR IL1A

Drugs & Therapeutics for Cryptosporidiosis

Drugs for Cryptosporidiosis (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 49)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Nitazoxanide Approved, Investigational, Vet_approved Phase 3,Phase 2,Phase 1 55981-09-4 41684
2
Azithromycin Approved Phase 3,Phase 1,Phase 2 83905-01-5 53477736 447043 55185
3
Fluconazole Approved, Investigational Phase 3,Phase 2 86386-73-4 3365
4
Miconazole Approved, Investigational, Vet_approved Phase 3,Phase 2 22916-47-8 4189
5
Rifabutin Approved, Investigational Phase 3 72559-06-9 6323490
6
Sertraline Approved Phase 3 79617-96-2 68617
7 Anti-Infective Agents Phase 3,Phase 2,Phase 1
8 Antiparasitic Agents Phase 3,Phase 2,Phase 1
9 Anti-Bacterial Agents Phase 3,Phase 2,Phase 1
10 Antibiotics, Antitubercular Phase 3
11 Antifungal Agents Phase 3,Phase 2
12 Antitubercular Agents Phase 3
13 Cytochrome P-450 CYP2C9 Inhibitors Phase 3,Phase 2
14 Cytochrome P-450 Enzyme Inhibitors Phase 3,Phase 2
15 Hormone Antagonists Phase 3,Phase 2
16 Hormones Phase 3,Phase 2
17 Hormones, Hormone Substitutes, and Hormone Antagonists Phase 3,Phase 2
18 Steroid Synthesis Inhibitors Phase 3,Phase 2
19 Antiprotozoal Agents Phase 3,Phase 2,Phase 1
20 Antidepressive Agents Phase 3
21 Neurotransmitter Agents Phase 3
22 Neurotransmitter Uptake Inhibitors Phase 3
23 Psychotropic Drugs Phase 3
24
Serotonin Phase 3 50-67-9 5202
25 Serotonin Agents Phase 3
26 Serotonin Uptake Inhibitors Phase 3
27
Paromomycin Approved, Investigational Phase 2,Phase 1 7542-37-2, 1263-89-4 165580
28
Clofazimine Approved, Investigational Phase 2 2030-63-9 2794
29
Flucytosine Approved, Investigational Phase 2 2022-85-7 3366
30 Anti-Inflammatory Agents Phase 2
31 Adjuvants, Immunologic Phase 1, Phase 2
32 Angiogenesis Inhibitors Phase 1, Phase 2
33 Angiogenesis Modulating Agents Phase 1, Phase 2
34 Interleukin-12 Phase 1, Phase 2
35 Antimetabolites Phase 2
36
Loperamide Approved Phase 1 53179-11-6 3955
37
Spiramycin Approved Phase 1 24916-50-5
38 Antibodies Phase 1
39 Antidiarrheals Phase 1
40 Immunoglobulins Phase 1
41 Vaccines Phase 1
42 Whey Protein Nutraceutical Phase 1
43
Formaldehyde Approved, Vet_approved 50-00-0 712
44 Diclazuril
45 gamma-Globulins
46 Immunoglobulins, Intravenous
47 Rho(D) Immune Globulin
48 Disinfectants
49 Ether

Interventional clinical trials:

(show all 29)

# Name Status NCT ID Phase Drugs
1 Optimal Time to Start Antiretroviral Therapy in HIV-infected Adults With Cryptococcal Meningitis Completed NCT00976040 Phase 4
2 A Randomized Study of Daily and Intermittent Prophylactic Regimens for the Prevention of Disseminated Mycobacterium Avium Complex (MAC) and Fungal Infections in HIV-Infected Patients Completed NCT00002122 Phase 3 Azithromycin;Rifabutin;Fluconazole
3 Cryptococcal Antigen Screening Plus Sertraline Recruiting NCT03002012 Phase 3 Sertraline;Placebo Oral Tablet;Fluconazole
4 Safety and Effectiveness of Nitazoxanide for the Treatment of Cryptosporidiosis in AIDS Patients Terminated NCT00004986 Phase 3 Nitazoxanide
5 A Double-Blind, Placebo-Controlled Trial of Paromomycin for Treatment of Cryptosporidiosis in Patients With Advanced HIV Disease and CD4 Counts Under 150 Cells/mm3 Completed NCT00000771 Phase 2 Paromomycin sulfate
6 A Study of Nitazoxanide in Patients With AIDS and Diarrhea Caused by Cryptosporidium Completed NCT00001081 Phase 2 Nitazoxanide
7 Nitazoxanide for the Treatment of Chronic Diarrhea in HIV Infected Children Completed NCT00055107 Phase 1, Phase 2 Nitazoxanide
8 A Phase 2A Evaluation of the Safety, Tolerability, Pharmacokinetics, Efficacy of Clofazimine (CFZ) in Cryptosporidiosis Not yet recruiting NCT03341767 Phase 2 Clofazimine;Placebo
9 Interleukin 12 (IL-12) for the Treatment of Cryptosporidiosis in AIDS Patients Terminated NCT00057486 Phase 1, Phase 2 IL-12
10 Safety Study of Fluconazole in Combination With Flucytosine for the Treatment of Early Cryptococcal Infection Terminated NCT01562132 Phase 2 Flucytosine and fluconazole;Fluconazole
11 A Study of Letrazuril in the Treatment of AIDS-Related Diarrhea Completed NCT00001018 Phase 1 Letrazuril
12 A Randomized, Multicenter, Double-Blind, Parallel-Group, Placebo-Controlled Trial of the Efficacy and Safety of Bovine Anti-Cryptosporidium Immunoglobulin (BACI) in the Treatment of Cryptosporidium Enteritis in AIDS Patients Completed NCT00002248 Phase 1 Cryptosporidium Immune Whey Protein Concentrate (Bovine)
13 A Study of Spiramycin in the Treatment of Patients With AIDS-Related Diarrhea Completed NCT00000980 Phase 1 Spiramycin
14 A Study of Nitazoxanide in the Treatment of AIDS-Related Diarrhea Completed NCT00002444 Phase 1 Nitazoxanide
15 A Study to Evaluate the Use of Nitazoxanide to Treat Cryptosporidiosis Unknown status NCT00002158 Nitazoxanide
16 Transmission and the Respiratory Tract in Cryptosporidiosis Completed NCT00507871
17 Azithromycin in the Treatment of Cryptosporidiosis in Patients Who Have Not Had Success With Other Drugs Completed NCT00002328 Azithromycin
18 Azithromycin in the Treatment of Cryptosporidiosis in Patients With Acquired Immune Deficiency Syndrome (AIDS): A Randomized, Multi-Center, Placebo-Controlled, Double-Blind Study Completed NCT00002082 Azithromycin
19 Protocol For the Treatment of Cryptosporidiosis in AIDS Patients With Diclazuril (R64,433) Completed NCT00002027 Diclazuril
20 A 28-Day Study of Diclazuril in the Treatment of Cryptosporidiosis in Patients With AIDS Completed NCT00002278 Diclazuril
21 Open-Label "Compassionate" Use Study of Spiramycin for the Treatment of Diarrhea Due to Chronic Cryptosporidiosis in Immunocompromised Patients Completed NCT00002062 Spiramycin
22 The Effectiveness of Cow's Milk Immune Globulin in the Treatment of AIDS-Related Diarrhea Completed NCT00002264 Cryptosporidium Immune Whey Protein Concentrate (Bovine)
23 Trial of Ceramic Water Filters to Reduce Cryptosporidium Infection in Kenya Completed NCT01695304
24 Field Studies of Amebiasis in Bangladesh Completed NCT02734264
25 Breast Milk Composition and HIV-exposed/Unexposed Early Infant Growth and Infectious Disease Events Completed NCT01699841
26 Diagnosis of Neglected Tropical Diseases Among Patients With Persistent Digestive Disorders Completed NCT02105714
27 Cryptosporidiosis and Enteropathogens in Bangladesh Active, not recruiting NCT02764918
28 Treatment of Chronic Cryptosporidiosis in AIDS Patients Terminated NCT00001128 Interleukin-12;Paromomycin sulfate;Azithromycin
29 Parasitic Infections of the Gastrointestinal Tract Terminated NCT00001162

Search NIH Clinical Center for Cryptosporidiosis

Inferred drug relations via UMLS 69 / NDF-RT 47 :


Cochrane evidence based reviews: cryptosporidiosis

Genetic Tests for Cryptosporidiosis

Anatomical Context for Cryptosporidiosis

MalaCards organs/tissues related to Cryptosporidiosis:

38
Small Intestine, Lung, Breast, Colon, Testes, Liver, T Cells

Publications for Cryptosporidiosis

Articles related to Cryptosporidiosis:

(show top 50) (show all 628)
# Title Authors Year
1
The existing drug vorinostat as a new lead against cryptosporidiosis by targeting the parasite histone deacetylases. ( 29300993 )
2018
2
A Novel Piperazine-Based Drug Lead for Cryptosporidiosis from the Medicines for Malaria Venture Open Access Malaria Box. ( 29339392 )
2018
3
Foodborne cryptosporidiosis. ( 29122606 )
2018
4
Clinical and microbiologic efficacy of the piperazine-based drug lead MMV665917 in the dairy calf cryptosporidiosis model. ( 29309415 )
2018
5
Has respiratory cryptosporidiosis spread to black grouse Tetrao tetrix? ( 28893970 )
2017
6
Pediatric cryptosporidiosis: An evaluation of health care and societal costs in Peru, Bangladesh and Kenya. ( 28832624 )
2017
7
Atorvastatin repurposing for the treatment of cryptosporidiosis inA experimentally immunosuppressed mice. ( 28764965 )
2017
8
Cryptosporidiosis Outbreak Associated With a Single Hotel. ( 29154521 )
2017
9
Associations between extreme precipitation and acute gastro-intestinal illness due to cryptosporidiosis and giardiasis in an urban Canadian drinking water system (1997-2009). ( 29215354 )
2017
10
Economic Assessment of Waterborne Outbreak of Cryptosporidiosis. ( 28930007 )
2017
11
Molecular Epidemiology of Cryptosporidiosis in China. ( 28932217 )
2017
12
Three-dimensional (3D) culture of adult murine colon as an in vitro model of cryptosporidiosis: Proof of concept. ( 29230047 )
2017
13
Diarrhea and malnutrition in kidney transplant recipient: A case of infection by cryptosporidiosis. ( 28648208 )
2017
14
Cryptosporidium and cryptosporidiosis: The Asian perspective. ( 28760503 )
2017
15
Design and Solidification of Fast-Releasing Clofazimine Nanoparticles for Treatment of Cryptosporidiosis. ( 28929769 )
2017
16
Evaluation of enzyme linked immunosorbent assay for stool antigen detection for the diagnosis of cryptosporidiosis among HIV negative immunocompromised patients in a tertiary care hospital of northern India. ( 28668658 )
2017
17
Cryptosporidiosis outbreak at an academic animal research laboratory-Colorado, 2014. ( 28079280 )
2017
18
Lessons Learned from Protective Immune Responses to Optimize Vaccines against Cryptosporidiosis. ( 29295550 )
2017
19
Occupational Animal Exposure Among Persons with Campylobacteriosis and Cryptosporidiosis - Nebraska, 2005-2015. ( 28910275 )
2017
20
A Retrospective Cohort Study of an Outbreak of Cryptosporidiosis among Veterinary Students. ( 29056688 )
2017
21
Cryptosporidiosis in a transplant recipient with severe intractable diarrhea: Detection of Cryptosporidium oocysts by intestinal biopsies. ( 29277954 )
2017
22
Bovine cryptosporidiosis: impact, host-parasite interaction and control strategies. ( 28800747 )
2017
23
Clinical Manifestations of Cryptosporidiosis and Identification of a New Cryptosporidium Subtype in Patients From Sonora, Mexico. ( 28858043 )
2017
24
New Tools for Cryptosporidium Lead to New Hope for Cryptosporidiosis. ( 28750950 )
2017
25
Cryptosporidiosis ( 28846353 )
2017
26
Natural History of Cryptosporidiosis in a Birth Cohort in Southern India. ( 28013266 )
2017
27
Waterparks are high risk for cryptosporidiosis: A case-control study in Victoria, 2015. ( 28899309 )
2017
28
Indian Ocean Dipole and Cryptosporidiosis in Australia: Short-Term and Nonlinear Associations. ( 28650648 )
2017
29
Waterborne outbreak of cryptosporidiosis in the South East of Ireland: weighing up the evidence. ( 28084584 )
2017
30
Advances in bumped kinase inhibitors for human and animal therapy for cryptosporidiosis. ( 28899690 )
2017
31
Diagnostic biomarkers in murine Cryptosporidiosis: dose- and age-related infection. ( 28848287 )
2017
32
Targeting Prolyl-tRNA Synthetase to Accelerate Drug Discovery against Malaria, Leishmaniasis, Toxoplasmosis, Cryptosporidiosis, and Coccidiosis. ( 28867614 )
2017
33
Cryptosporidiosis: A mini review. ( 29114483 )
2017
34
A Novel Calcium-Dependent Kinase Inhibitor, Bumped Kinase Inhibitor 1517, Cures Cryptosporidiosis in Immunosuppressed Mice. ( 27738055 )
2016
35
Cryptosporidium Priming Is More Effective than Vaccine for Protection against Cryptosporidiosis in a Murine Protein Malnutrition Model. ( 27467505 )
2016
36
Cryptosporidiosis Drug Discovery: Opportunities and Challenges. ( 27626293 )
2016
37
Human cryptosporidiosis in Europe. ( 27172805 )
2016
38
Pulmonary cryptosporidiosis in an immunocompetent host treated successfully with nitazoxanide. ( 26933311 )
2016
39
Cryptosporidium and cryptosporidiosis: the African perspective. ( 27126869 )
2016
40
Clinical Characteristic of the HIV/AIDS Patients with Cryptosporidiosis Referring to Behavioral Diseases Consultation Center, Imam Khomeini Hospital, Tehran in 2013. ( 26870140 )
2016
41
Spatial Modelling Tools to Integrate Public Health and Environmental Science, Illustrated with Infectious Cryptosporidiosis. ( 26848669 )
2016
42
Acute, Severe Cryptosporidiosis in an Immunocompetent Pediatric Patient. ( 27478580 )
2016
43
Secondary transmission of cryptosporidiosis associated with well water consumption: two case studies. ( 27192601 )
2016
44
Protein Malnutrition Impairs Intestinal Epithelial Cell Turnover, a Potential Mechanism of Increased Cryptosporidiosis in a Murine Model. ( 27736783 )
2016
45
Comparison of different diagnostic techniques for the detection of cryptosporidiosis in bovines. ( 27051211 )
2016
46
Discovery of new variable number tandem repeat loci in multiple Cryptosporidium parvum genomes for the surveillance and investigation of outbreaks of cryptosporidiosis. ( 27523797 )
2016
47
Novel Bumped Kinase Inhibitors Are Safe and Effective Therapeutics in the Calf Clinical Model for Cryptosporidiosis. ( 27923949 )
2016
48
Assessment of microscopic and molecular tools for the diagnosis and follow-up of cryptosporidiosis in patients at risk. ( 26610340 )
2016
49
Cryptosporidiosis Risk in New Zealand Children Under 5 Years Old is Greatest in Areas with High Dairy Cattle Densities. ( 27766441 )
2016
50
The Brief Case: Cryptosporidiosis in a Severely Immunocompromised HIV Patient. ( 27578154 )
2016

Variations for Cryptosporidiosis

Expression for Cryptosporidiosis

Search GEO for disease gene expression data for Cryptosporidiosis.

Pathways for Cryptosporidiosis

Pathways related to Cryptosporidiosis according to GeneCards Suite gene sharing:

# Super pathways Score Top Affiliating Genes
1 11.34 IL1A SST TAC1
2 10.89 CD40LG CD79A
3 10.79 CCL11 CXCL10
4 10.36 CCL11 CD40LG CXCL10 IL1A
5 10.15 CCL11 CD40LG CXCL10 IL1A

GO Terms for Cryptosporidiosis

Cellular components related to Cryptosporidiosis according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 extracellular space GO:0005615 9.5 CAT CCL11 CD40LG CXCL10 IL1A SST
2 extracellular region GO:0005576 9.23 CAT CCL11 CD40LG CXCL10 IL1A SST

Biological processes related to Cryptosporidiosis according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 G-protein coupled receptor signaling pathway GO:0007186 9.72 CCL11 CXCL10 SST TAC1 VIP
2 immune response GO:0006955 9.46 CCL11 CD40LG CXCL10 IL1A
3 inflammatory response GO:0006954 9.35 CCL11 CD40LG CXCL10 IL1A TAC1
4 B cell proliferation GO:0042100 9.26 CD40LG CD79A
5 regulation of receptor activity GO:0010469 9.1 CCL11 CD40LG CXCL10 IL1A SST VIP

Molecular functions related to Cryptosporidiosis according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 NADP binding GO:0050661 8.96 CAT DHFR
2 cytokine activity GO:0005125 8.92 CCL11 CD40LG CXCL10 IL1A

Sources for Cryptosporidiosis

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
16 ExPASy
18 FMA
27 GO
28 GTR
29 HGMD
30 HMDB
31 HPO
32 ICD10
33 ICD10 via Orphanet
34 ICD9CM
35 IUPHAR
36 KEGG
37 LifeMap
39 MedGen
41 MeSH
42 MESH via Orphanet
43 MGI
45 NCI
46 NCIt
47 NDF-RT
50 NINDS
51 Novoseek
53 OMIM
54 OMIM via Orphanet
58 PubMed
60 QIAGEN
65 SNOMED-CT via HPO
66 SNOMED-CT via Orphanet
67 TGDB
68 Tocris
69 UMLS
70 UMLS via Orphanet
Content
Loading form....